IN VITRO α-AMYLASE AND α-GLUCOSIDASE INHIBITOR ACTIVITY OF ABUTILON INDICUM LEAVES

Authors

  • Geetika Pant Indian Academy Centre for Research and Post Graduate Studies
  • Krishna Sai
  • S Babasaheb
  • Rajashekar Reddy
  • Sibi G Indian Academy Centre for Research and Post Graduate Studies

Abstract

Postprandial hyperglycemia caused by the hydrolysis of carbohydrates by pancreatic α-amylase and intestinal α-glucosidase is a serious condition and inhibition of these enzymes is an effective way in the management of diabetes mellitus. Abutilon indicum (L.) Sweet leaves were used to determine their in vitro α-amylase and α-glucosidase inhibitory activity. Various concentrations from 10 µg ml-1 to 160 µg ml -1 were prepared in methanol along with the standard antidiabetic drug, acarbose. There was a dose dependent percent inhibition by the extract against α-amylase (7.12% - 41.31%) and α-glucosidase (8.01% - 36.13%). Logarithmic regression analysis revealed the IC50 of 129.89 µg ml-1 (α-amylase) and 137.61 µg ml-1 (α-glucosidase) with a potency and preference for α-amylase over α-glucosidase inhibition by the A. indicum leaf extract. 

Downloads

Download data is not yet available.

References

Kwon YI, Apostolidis E, Kim YC, Shetty K. Health benefits of traditional corn, beans and pumpkin: In vitro studies for hyperglycemia and hypertension management. J Med Food 2007; 10: 266 - 275.

Cheng AYY, Fantus IG, Oral antihyperglycemic therapy for type 2 diabetes mellitus. Canadian Medicinal Association Journal. 2005; 172(2): 213-226.

Hanefeld M, The role of acarbose in the treatment of non-insulin-dependent diabetes mellitus. J Diabetes Complications. 1998; 12:228-237.

Grover JK, Yadav S, Vats V, Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002; 81: 81-100.

Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ, Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol. 2006; 106(1): 1-28.

Ribnicky DM, Poulev A, Watford M, Cefalu WT, Raskin I, Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L. Phytomedicine. 2006; 13: 550-557.

Kirtikar KR, Basu BD. 1994. Indian Medicinal Plants, 2nd Edn, Vol. I, Dehradun. 314-317.

Prajapati ND, Purohit SS, Sharma AK, Kumar TA, Handbook of Medicinal Plants, Agrobios, (India) Jodhpur. 2003; 3.

Sharma PV, Ahmed ZA, Sharma VV, Analgesic constituent of Abutilon indicum. Indian drugs. 1989; 26 (7): 333.

Nadkarni KM, 1954. The Indian Materia Medica 3rd Edn., Popular Prakashan, Bombay, Vol: 1.

Tripathi P, Chauhan NS, Patel JR, Anti-inflammatory effect of Abutilon indicum extract. Nat Prod Res. 2012; 26(17): 1659-1651.

Mehta BK, Neogi R, Kotra S, Mall OP, Antimicrobial activity of Abutilon indicum. Fitoterapia, 1997; 68(3): 273-274.

Pandey DK, Tripathy RD, Tripathy NN, Dixit SN, Antifungal activity of some seed extracts with special reference to that of Pimpinella diversifolia DC. Indian Journal of Crude Drug Research. 1983; 21(4): 177-182.

Vairavasundaram RP, Senthil K, Antimycotic activity of the components of Abutilon indicum (Malvaceae), Drug Invention Today. 2009; 1(2): 137-139.

Chandrashekhar VM, Nagappa AN, Channesh TS, Habbu PV, Rao KP, Antidiarrhoeal activity of Abutilon indicum leaf extracts. Journal of Natural Remedies. 2004; 4(1): 12-16.

Rahuman AA, Gopalakrishnan G, Venkatesan P, Kannappan G, Isolation and identification of mosquito larvicidal compound from Abutilon indicum (Linn.) Sweet. Parasitol Research. 2008; 102: 981-988.

Porchezhian E, Ansari SH, Hepatoprotective activity of Abutilon indicum on experimental liver damage in rats. Phytomedicine. 2005; 12(1-2): 62-64.

Dash GK, Samanta A, Kanungo SK, Shau SK, Suresh P, Ganpathy S, Hepatoprotective activity of leaves of Abutilon indicum. Indian Journal of Natural Products. 2000; 16(2): 25-27.

Srividya AR, Dhanabal SP, Jeevita S, Vishnuvarthan VJ, Rajeshkumar R, Relationship between Antioxidant Properties and Chemical Composition of Abutilon indicum Linn. Indian J Pharm Sci. 2012; 74(2): 163-167.

Yasmin S, Kashmiri MA, Asghar MN, Ahmad M, Mohy-ud-Din A, Antioxidant potential and radical scavenging effects of various extracts from Abutilon indicum and Abutilon muticum. Pharm. Biol. 2010, 48(3): 282-289.

Johri RK, Pahwa GS, Sharma SC, Zutshi U, Determination of estrogenic/ antiestrogenic potential of antifertility substances using rat uterine peroxidase assay. Contraception. 1991; 44(5): 549-557.

Seetharam YN, Chalageri G, Setty SR, Bheemachar, Hypoglycemic activity of Abutilon indicum leaf extracts in rats. Fitoterapia. 2002; 73 (2): 156-159.

Krisanapun C, Lee SH, Peungvicha P, Temsiririrkkul R, Baek SJ, Antidiabetic activities of Abutilon indicum (L.) Sweet are mediated by enhancement of adipocyte differentiation and activation of the GLUT1 Promoter. Evid Based Complement Alternat. Med. 2011; 167684.

Krisanapun C, Peungvicha P, Temsiririrkkul R, Wongkrajang Y, Aqueous extract of Abutilon indicum Sweet inhibits glucose absorption and stimulates insulin secretion in rodents, Nutr. Res. 2009; 29(8): 579-587.

Trease GE, Evans WC, Pharmacognosy, 15th ed. 2002; Springer, Berlin.

Sofowora A, Screening plants for bioactive agents. In: Medicinal Plants and Traditional Medicinal in Africa, 2nd ed., Spectrum Books Ltd., Sunshine House, Ibadan, Nigeria, 1993; pp. 134-156.

Bernfield P, Enzymes of starch degradation and synthesis. Adv Enzymol. 1951; 12: 379 - 380.

Apostolidis E, Kwon YI, Shetty K, Inhibitory potential of herb, fruit, and fungus enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Inn Food Sci Emerg Technol. 2007; 8: 46-54.

Oboh G, Ademiluyi AO, Faloye YM, Effect of combination on the antioxidant and inhibitory properties of tropical pepper varieties against α-amylase and α-glucosidase activities in vitro. J Med Food. 2011; 14:1152-1158.

Dineshkumar B, Mitra A, Mahadevappa M, Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from Murraya koenigii (rutaceae) leaves. Int J Phytomed. 2010; 13:22-30.

Sharma B, Salunke R, Balomajumder C, Daniel S, Roy P, Anti-diabetic potential of alkaloid rich fraction from Capparis decidua on diabetic mice. J Ethnopharmacol. 2010; 13:457-462.

Panda S, Kar A, Apigenin (4′,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice. J Pharm Pharmacol. 2007; 13:1543-1548.

Yoshikawa M, Wang T, Morikawa T, Xie H, Matsuda H, Bioactive Constituents from Chinese Natural Medicines. XXIV. Hypoglycemic Effects of Sinocrassula indica in Sugar-Loaded Rats and Genetically Diabetic KK-Ay Mice and Structures of New Acylated Flavonol Glycosides, Sinocrassosides A1, A2, B1, and B2. Chem Pharm Bull. 2007; 55:1308-1315.

Manickam M, Ramanathan M, Jahromi MA, Chansouria JP, Ray AB, Antihyperglycemic activity of phenolics from Pterocarpus marsupium. J Nat Prod. 1997; 13: 609-610.

Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ, Tang CP, et al, Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol. 2008; 13:263-273.

Contreras C, Roman R, Perez C, Alarcon F, Zavala M, Perez S, Hypoglycemic activity of a new carbohydrate isolated from the roots of Psacalium peltatum. Chem Pharm Bull. 2005; 13:1408-1410.

Lakshmayya, Nelluri NR, Kumar P, Agarwal NK, Gouda TS, Setty SR, Phytochemical and pharmacological evaluation of leaves of Abutilon indicum. Indian Journal of Traditional Knowledge. 2003; 2(1): 79-83.

Ramasubramaniaraja R, Pharmacognostical phytochemical including GC-MS investigation of ethanolic leaf extracts of Abutilon indicum (Linn), Asian Journal of Pharm. Ana. 2011; 1(4): 88-92.

Anam K, Widharna RM, Kusrini D, α-glucosidase inhibitor activity of Terminalia species. Int J Pharmacol, 2009; 5: 277-280.

Tarling CA, Woods K, Zhang R, Brastianos HC, Brayer GD, Andersen RJ, et al, The Search for Novel Human Pancreatic α-Amylase Inhibitors: High-Throughput Screening of Terrestrial and Marine Natural Product Extracts. Chem BioChem. 2008; 9: 433-438.

Layer P, Rizza RA, Zinsmeister AR, Carlson GL, DiMagno EP, Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus. Mayo Clin Proc. 1986; 61(6): 442-447.

Tundis R, Loizzo MR, Menichini F, Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycemic potential in the treatment of diabetes: an update. Mini Rev Med Chem. 2010; 10(4):315-331.

Samad A, Shams MS, Ullah Z, Wais M, Nazish I, Sultana Y, et al, Status of herbal medicines in the treatment of diabetes: a review. Current Diabetes Reviews. 2009; 5(2):102-111.

Chiba S, Molecular mechanism in a-glucosidase and glucoamylase. Biosci Biotechnol Biochem. 1997; 61:1233-1239.

Published

01-11-2013

How to Cite

Pant, G., K. Sai, S. Babasaheb, R. Reddy, and S. G. “IN VITRO α-AMYLASE AND α-GLUCOSIDASE INHIBITOR ACTIVITY OF ABUTILON INDICUM LEAVES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 6, no. 9, Nov. 2013, pp. 22-24, https://mail.innovareacademics.in/journals/index.php/ajpcr/article/view/402.

Issue

Section

Articles